Astellas Pharma Inc 2018 SR
The report outlines Astellas Pharma's environmental performance for fiscal 2017, focusing on climate change, resource management, and biodiversity. The company achieved a 30% reduction in greenhouse gas emissions compared to 2005 levels and committed to Science Based Targets (SBT) for future reductions. Significant progress was made in water resource productivity, which improved 2.9 times since 2005. The report also details initiatives for waste management, pollution prevention, and the adoption of renewable energy sources across global operations.
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2018
Type: SR
Pages: 20
Back to company
Astellas Pharma Inc
Environment Report
The report outlines Astellas Pharma's environmental performance for fiscal 2017, focusing on climate change, resource management, and biodiversity. The company achieved a 30% reduction in greenhouse gas emissions compared to 2005 levels and committed to Science Based Targets (SBT) for future reductions. Significant progress was made in water resource productivity, which improved 2.9 times since 2005. The report also details initiatives for waste management, pollution prevention, and the adoption of renewable energy sources across global operations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2017 - Mar 31, 2018
Fiscal Year
2017
Published
Jun 1, 2018
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Employees